Overall, these findings suggest that the re‐expression of SLC27A5 or inhibition of CA accumulation ameliorates the pathogenesis of liver fibrosis, providing a potential strategy for treating this condition. The gene discussed is SLC27A5; the disease is Hepatic fibrosis.